Global Pharmaceutical Packaging Market Size is valued at USD 134.3 Billion in 2024 and is predicted to reach USD 356.7 Billion by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Increased frequency of persistent and infectious illnesses, increased expenditure in pharmaceutical R&D, improved earnings, and expanded health service have all enhanced pharmaceutical manufacturing. Additionally, patent expirations and the growing manufacture of generic medicines lead to increased production, boosting pharmaceutical output and rising packaging needs.
The pharmaceutical industry demands dependable, quick-packed solutions addressing adequate protection, counterfeit evidence, quality, patient comfort, and security concerns. Consistent and ongoing innovation in the pharmaceutical industry, such as Plasma Impulse Chemical Vapor Deposition (PICVD) coating technology, unit dose vials, Blow Fill Seal (BFS) vials, two-in-one prefilled vial design, and baby packs, is expected to see an increase in demand. The market is predicted to rise due to a strong pharma production base and capital efficiency in technology advancements for sustainable packaging.
The burgeoning pharmaceutical sector in the region's developing nations is expected to increase demand for pharmaceutical packaging due to rising health awareness, regulatory norms, and a growing emphasis on population health management. Furthermore, the ever-increasing demand for hospital pharmaceuticals and medicines is projected to boost the market growth. Certain medicines utilize animal, microbe, plant, or cell cultures. They are frequently vulnerable to contamination and heat sensitivity, which is expected to fuel requests for packing solutions, resulting in a rise in the pharmaceutical packaging market growth.
The pharmaceutical packaging market is segmented on material, product and end user. Material segment includes plastics & polymers, polyvinyl chloride (PVC), polypropylene (PP), polyethylene terephthalate (PET), polyethylene (PE), paper & paperboard, glass, aluminum foil and others. Based on product, the market is segmented as primary, secondary and tertiary. By product, the market is segmented into. By product, the market is segmented into. Based on Drug Delivery, the pharmaceutical packaging market is segmented as oral, pulmonary, transdermal, injectable, topical, nasal, ocular/ophthalmic, intravenous, and other drug delivery modes. Based on end users, the pharmaceutical packaging market is segmented as pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy.
The plastic & polymers category will hold a major share of the global pharmaceutical packaging market in 2024. Blister packs, strip7 packs, sachets, pre-fillable syringes and inhalers, parenteral solution bags, and bottles are all packaged with plastics. Pharmaceutical packaging materials must be chemically inert, have low water vapor permeability, and easily handle.
Furthermore, because the packing materials come into close touch with drugs and biological agents, they must adhere to stringent regulatory requirements. Polymers and polymers meet these specifications and are commonly employed in pharmaceutical packaging. Plastics are in high demand in the pharmaceutical sector because they provide a cost-effective and dependable method of packaging pharmaceutical items. Thermoplastics and thermosets are two polymers commonly used in pharmaceutical product packaging to safeguard sealed medicinal items.
The primary packaging segment is projected to rise in the global pharmaceutical packaging market. Product benefits such as product testing, taint prevention, transit safety, and better results will drive product demand in the next years. Medication tubes, caps and closures, soda containers, blister packs, parenteral containers, pouches, pre-fillable inhalers, and others comprise the principal packaging product group. Plastic bottles are the most utilized product for packaging various sorts of drugs, and as such, they have emerged as the dominant packaging product leader.
The Injectables are expected to hold a significant share of the global pharmaceutical packaging market. Injectable drug delivery systems are recognized as very successful and efficient drug administration techniques because they swiftly and efficiently deliver medications to the intended location. Most drugs are administered orally or by injection, even though injectables can be self-injecting devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. Because of technical advancements, a vast array of better and more sophisticated technologies has been created. Plastic is the raw material in the pharmaceutical packaging market that is expected to increase at the fastest rate during the forecast period. Plastics are permeable to moisture, oxygen, and carbon dioxide unless the container is colored. Additionally, they allow light rays to go through.
The North American pharmaceutical packaging market is expected to register the highest market share in revenue shortly. Leading pharmaceutical companies with considerable presence in the region include Canada, the United States, and Mexico. Because of its extensive healthcare system, elevated expenditure on drug discovery, and high per capita income, the United States has the world's largest pharmaceutical market.
In addition, Asia Pacific is projected to expand at a quick rate in the global pharmaceutical packaging market; Japan, India, China, and South Korea are some of the essential needs due to fast-growing populations and sustained economic growth in the area, which are expected to drive packaging demand in the following years. Furthermore, favorable government laws on drug safety are projected to enhance the region's growth.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 134.3 Bn |
|
Revenue forecast in 2034 |
USD 356.7 Bn |
|
Growth rate CAGR |
CAGR of 10.4% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Mn, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Material, Product, Drug Delivery And End User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico; The UK; France; Italy; Spain; Japan; India; South Korea; Southeast Asia |
|
Competitive Landscape |
Amcor plc; Becton, Dickinson, and Company; AptarGroup, Inc.; Drug Plastics Group; Hergesheimer AG; Schott AG; Owens Illinois, Inc.; West Pharmaceutical Services, Inc.; Berry Global, Inc.; WestRock Company; SGD Pharma; International Paper; Comer, LLC; CCL Industries, Inc.; Vetter Pharma International |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharmaceutical Contract Packaging Market Snapshot
Chapter 4. Global Pharmaceutical Contract Packaging Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Pharmaceutical Contract Packaging Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Pharmaceutical Contract Packaging Market Industry Trends
Chapter 5. Pharmaceutical Contract Packaging Market Segmentation 1: By Material, Estimates & Trend Analysis
5.1. Market Share by Material, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Material:
5.2.1. Plastic
5.2.2. Glass
5.2.3. Aluminum Foil
5.2.4. Paper & Paperboard
5.2.5. Others
Chapter 6. Pharmaceutical Contract Packaging Market Segmentation 2: By Type, Estimates & Trend Analysis
6.1. Market Share by Type, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
6.2.1. Primary Packaging
6.2.2. Secondary Packaging
Chapter 7. Pharmaceutical Contract Packaging Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Pharmaceutical Manufacturing Companies
7.2.2. Biopharmaceutical Companies
7.2.3. Contract Research Organizations
7.2.4. Others
Chapter 8. Pharmaceutical Contract Packaging Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Pharmaceutical Contract Packaging Market, Regional Snapshot 2023 & 2034
8.2. North America
8.2.1. North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.2.3. North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.4. North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.3.3. Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.4. Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.4.3. Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.4. Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.5.3. Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.4. Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.6.3. Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.6.4. Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Catalent, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. AbbVie Contract Manufacturing
9.2.3. Patheon (Thermo Fisher Scientific)
9.2.4. Baxter BioPharma Solutions
9.2.5. Nipro Corporation
9.2.6. Pfizer CentreOne
9.2.7. Recipharm AB
9.2.8. Vetter Pharma International GmbH
9.2.9. NextPharma Technologies
9.2.10. Sharp
9.2.11. Others
Pharmaceutical Packaging Market By Material
Pharmaceutical Packaging Market By Product
Pharmaceutical Packaging Market By Drug Delivery
Pharmaceutical Packaging Market By End-use
Pharmaceutical Packaging Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
